Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The Integrative Cancer Epidemiology Programme

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.03.18
Views: 671

Prof Richard Martin - University of Bristol, Bristol, UK

Richard Martin speaks with ecancer about the Integrative Cancer Epidemiology Programme (ICEP).

He highlights the international collaboration and open-access provision of data to the project, which seeks to determine biomarkers, predictive risk factors and potential drug design and interaction based -omic data from thousands of patients.

Dr Martin notes links to obesity and DNA methylation as two risk factors already highlighted in consortium data.

For more on the data and analysis tools used in the project, including MR Base and MELODI, click here.

Dr Martin also spoke with ecancer about PSA screening for prostate cancer, here.

Related videos

follow us

SIOG e-learning July 2017

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation